Polycystic ovaries and infertility: Our experience
- PMID: 19562048
- PMCID: PMC2700664
- DOI: 10.4103/0974-1208.44113
Polycystic ovaries and infertility: Our experience
Abstract
Background: Polycystic ovary syndrome (PCOS) is one of the most common (15-20%) endocrine disorders in women of childbearing age. Although it is a major cause of infertility, its etiology remains unknown and its treatment difficult.
Aim: To evaluate the incidence, treatment and outcome of patients with PCOS.
Design: Retrospective analysis.
Materials and methods: PCOS patients (914 of the 1057) attending the outpatient department (OPD) from June 2003 to February 2008 were evaluated for this study. Of the 914 patients investigated, 814 came for treatment and these patients were studied for hormonal disturbances and their response to various modalities of treatment.
Results: Of the 2270 infertility patients, 46.50% (1057) had PCOS, out of these, 86.47% (914) were investigated and 77% (814) came for treatment. Our overall pregnancy rate was 48.40% (394/814). The pregnancy rate per cycle with timed intercourse (TI) was 44.77% (47/105), 17.09% (286/1673) with intrauterine insemination (IUI), 29.82% (51/171) with in vitro fertilization (IVF) and 22.22% (10/45) with frozen embryo transfer (FET). The maximum number of pregnancies (85.29%, 284/333) were achieved in the first three treatment cycles. The abortion rate was 19.01% (73/384) and the incidence of ectopic pregnancy was 5.47% (21/384). Complications seen were in the form of ovarian hyperstimulation (OHSS), retention cyst on day two and multiple pregnancies in 11.71% (228/1946) of the total treatment cycles.
Conclusion: Most PCOS symptoms could be adequately controlled or eliminated with proper diagnosis and treatment. Thus, ovulation induction (OI) protocols and treatment modalities must be balanced for optimal results.
Keywords: Infertility; in vitro fertilization (IVF); intrauterine insemination (IUI); ovulation induction (OI); polycystic ovary syndrome (PCOS); pregnancy rate (PR); timed intercourse (TI); ultrasonography (USG).
Conflict of interest statement
Figures
References
-
- Balen AH, Conway GS, Kaltas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107–11. - PubMed
-
- The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19:41–7. - PubMed
-
- The Thessaloniki ESHRE/ASRM-Sponsored PCOS consensus workshop group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–77. - PubMed
-
- Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary; international consensus definitions. Hum Reprod update. 2003;9:505–14. - PubMed
-
- Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36:105–11. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials